All Stories

  1. Evaluating tisagenlecleucel and its potential in the treatment of relapsed or refractory diffuse large B cell lymphoma: evidence to date

    Article • OncoTargets and Therapy, June 2019, Dove Medical Press

    Phaedon Zavras